Clinical Trial Update: Randomized Study of Beta-Blockers and Antiplatelets in Patients With Spontaneous Coronary Artery Dissection [Phase 4]

View source ↗

Summary

Phase 4 randomized study assessing beta-blockers and antiplatelets in spontaneous coronary artery dissection is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spontaneous Coronary Artery Dissection

Snippet

Sponsor: Spanish Society of Cardiology | Conditions: Spontaneous Coronary Artery Dissection | Phase 4 | Status: NOT_YET_RECRUITING